Prelude Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning. I'm Kris Vaddi, Chief Executive Officer of Prelude Therapeutics Inc. Welcome to our 2026 Annual Meeting of Shareholders. I am a member of the Board of Directors and will serve as Chairperson of this annual meeting. And I now call the annual meeting to order.
With us today, we have Bryant Lim, Prelude's Chief Financial Officer, Chief Legal Officer, and Secretary; Peter Descovich of Broadridge Financial Solutions, Inc., Prelude's proxy tabulator; and Bryan Snellman of Ernst & Young LLP, Prelude's independent registered public accounting firm.
Peter Descovich has been appointed to act as the Inspector of Elections at this annual meeting by the Board of Directors and took the oath of Inspector of Election. Bryant Lim will act as Secretary of this annual meeting and keep the minutes.
And I will now turn the meeting over to Bryant.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
